Approach to the Child with Prader-willi Syndrome

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2012 Nov 7

PMID 23129592

Citations 24

Authors

Jennifer L Miller

Affiliations

Soon will be listed here.

Citing Articles

Premature adrenarche in Prader-Willi syndrome is associated with accelerated pre-pubertal growth and advanced bone age.

Gaston L, Stafford D J Pediatr Endocrinol Metab. 2022; 36(2):185-194.

PMID: 36458449 PMC: 10103844. DOI: 10.1515/jpem-2022-0468.

Epidemiology of Disorders Associated with Short Stature in Childhood: A 20-Year Birth Cohort Study in Finland.

Harju S, Saari A, Sund R, Sankilampi U Clin Epidemiol. 2022; 14:1205-1214.

PMID: 36320440 PMC: 9618248. DOI: 10.2147/CLEP.S372870.

Prader-Willi syndrome: an update on obesity and endocrine problems.

Kim S, Cho S, Jin D Ann Pediatr Endocrinol Metab. 2022; 26(4):227-236.

PMID: 34991300 PMC: 8749024. DOI: 10.6065/apem.2142164.082.

Evaluation and Management of Early Onset Genetic Obesity in Childhood.

Malhotra S, Sivasubramanian R, Srivastava G J Pediatr Genet. 2021; 10(3):194-204.

PMID: 34504723 PMC: 8416234. DOI: 10.1055/s-0041-1731035.

Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader-Willi Syndrome: A Polish Multicentre Study.

Lecka-Ambroziak A, Wysocka-Mincewicz M, Dolezal-Oltarzewska K, Zygmunt-Gorska A, Wedrychowicz A, Zak T J Clin Med. 2021; 10(14).

PMID: 34300343 PMC: 8305342. DOI: 10.3390/jcm10143176.

References

Nevsimalova S, Vankova J, Stepanova I, Seemanova E, Mignot E, Nishino S . Hypocretin deficiency in Prader-Willi syndrome. Eur J Neurol. 2004; 12(1):70-2. DOI: 10.1111/j.1468-1331.2004.00969.x. View

Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, Grandjean H . Endocrine disorders in children with Prader-Willi syndrome--data from 142 children of the French database. Horm Res Paediatr. 2010; 74(2):121-8. DOI: 10.1159/000313377. View

Haqq A, Farooqi I, ORahilly S, Stadler D, Rosenfeld R, Pratt K . Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab. 2003; 88(1):174-8. DOI: 10.1210/jc.2002-021052. View

Grugni G, Giardino D, Crino A, Malvestiti F, Ballarati L, Di Giorgio G . Growth hormone secretion among adult patients with Prader-Willi syndrome due to different genetic subtypes. J Endocrinol Invest. 2010; 34(7):493-7. DOI: 10.3275/7203. View

Williams K, Scheimann A, Sutton V, Hayslett E, Glaze D . Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy, and body composition. J Clin Sleep Med. 2008; 4(2):111-8. PMC: 2335405. View

Sanchez-Ortiga R, Klibanski A, Tritos N . Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis. Clin Endocrinol (Oxf). 2011; 77(1):86-93. DOI: 10.1111/j.1365-2265.2011.04303.x. View

Miller J, Lynn C, Shuster J, Driscoll D . A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome. J Hum Nutr Diet. 2012; 26(1):2-9. PMC: 4112078. DOI: 10.1111/j.1365-277X.2012.01275.x. View

Tan T, Vanderpump M, Khoo B, Patterson M, Ghatei M, Goldstone A . Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome. J Clin Endocrinol Metab. 2004; 89(8):4162-5. DOI: 10.1210/jc.2004-0835. View

De Waele K, Ishkanian S, Bogarin R, Miranda C, Ghatei M, Bloom S . Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome. Eur J Endocrinol. 2008; 159(4):381-8. DOI: 10.1530/EJE-08-0462. View

10.

Butler J, Whittington J, Holland A, Boer H, Clarke D, Webb T . Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol. 2002; 44(4):248-55. DOI: 10.1017/s001216220100202x. View

11.

van Nieuwpoort I, Deijen J, Curfs L, Drent M . The relationship between IGF-I concentration, cognitive function and quality of life in adults with Prader-Willi syndrome. Horm Behav. 2011; 59(4):444-50. DOI: 10.1016/j.yhbeh.2011.01.001. View

12.

Eiholzer U, lAllemand D, Schlumpf M, Rousson V, Gasser T, Fusch C . Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome. J Pediatr. 2004; 144(6):753-8. DOI: 10.1016/j.jpeds.2004.03.005. View

13.

Dauvilliers Y, Baumann C, Carlander B, Bischof M, Blatter T, Lecendreux M . CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry. 2003; 74(12):1667-73. PMC: 1757412. DOI: 10.1136/jnnp.74.12.1667. View

14.

Glenn C, Driscoll D, Yang T, Nicholls R . Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes. Mol Hum Reprod. 1997; 3(4):321-32. DOI: 10.1093/molehr/3.4.321. View

15.

Angulo M, Castro-Magana M, Lamerson M, Arguello R, Accacha S, Khan A . Final adult height in children with Prader-Willi syndrome with and without human growth hormone treatment. Am J Med Genet A. 2007; 143A(13):1456-61. DOI: 10.1002/ajmg.a.31824. View

16.

Mogul H, Lee P, Whitman B, Zipf W, Frey M, Myers S . Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial. J Clin Endocrinol Metab. 2008; 93(4):1238-45. DOI: 10.1210/jc.2007-2212. View

17.

Cochen De Cock V, Diene G, Molinas C, Dauriac-Le Masson V, Kieffer I, Mimoun E . Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome. Am J Med Genet A. 2011; 155A(7):1552-7. DOI: 10.1002/ajmg.a.34047. View

18.

Nyunt O, Cotterill A, Archbold S, Wu J, Leong G, Verge C . Normal cortisol response on low-dose synacthen (1 microg) test in children with Prader Willi syndrome. J Clin Endocrinol Metab. 2010; 95(12):E464-7. DOI: 10.1210/jc.2010-0647. View

19.

Farholt S, Sode-Carlsen R, Christiansen J, Ostergaard J, Hoybye C . Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome. J Clin Endocrinol Metab. 2010; 96(1):E173-80. DOI: 10.1210/jc.2010-0782. View

20.

Carrel A, Myers S, Whitman B, Eickhoff J, Allen D . Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome. J Clin Endocrinol Metab. 2010; 95(3):1131-6. PMC: 2841537. DOI: 10.1210/jc.2009-1389. View